To more accurately assess the stemness phenotype of GBM cells in the presence of ECs, we developed an orthotopic xenograft model by implanting tumor cells either alone or in conjunction with ECs at a 1:1 ratio, consistent with the IHC staining of CD31 from the xenografts (Figure 2I). This evidence concerns the gene PECAM1 and glioblastoma.